Drug Interaction Between Abilify (Aripiprazole) and Tegretol (Carbamazepine)
No, Abilify (aripiprazole) does not increase Tegretol (carbamazepine) levels. In fact, the opposite occurs - carbamazepine significantly decreases aripiprazole levels through enzyme induction.
Mechanism of Interaction
The interaction between aripiprazole and carbamazepine is primarily based on their metabolic pathways:
- Carbamazepine is a potent inducer of CYP3A4 enzymes in the liver 1
- Aripiprazole is extensively metabolized by CYP3A4 enzymes 2
- When used together, carbamazepine increases the metabolism of aripiprazole, resulting in decreased aripiprazole blood levels 2, 3
Clinical Significance and Management
Effect on Aripiprazole Levels
- Carbamazepine significantly reduces aripiprazole plasma concentrations through enzyme induction 3
- This can lead to reduced clinical efficacy of aripiprazole 3
- The FDA label specifically states: "When carbamazepine is added to aripiprazole, the aripiprazole dose should be doubled. Additional dose increases should be based on clinical evaluation." 1
Effect on Carbamazepine Levels
- There is no evidence that aripiprazole increases carbamazepine levels 2
- The FDA label for aripiprazole specifically states that "no dosage adjustment is necessary for valproate, lithium, lamotrigine, lorazepam, or sertraline when co-administered with aripiprazole" but does not include carbamazepine in this list 2
Recommendations for Clinical Practice
When prescribing these medications together:
- Double the aripiprazole dose when adding carbamazepine 2, 1
- Monitor for decreased aripiprazole efficacy even after dose adjustment 3
- Consider therapeutic drug monitoring of aripiprazole levels if available
- Watch for signs of treatment failure with aripiprazole due to subtherapeutic levels
Other Important Considerations
- While this combination doesn't increase carbamazepine levels, both medications can potentially affect liver function 3
- The combination should be used with caution and liver function tests should be monitored periodically 3
- Alternative mood stabilizers with fewer drug interactions (such as lamotrigine) may be considered if appropriate for the patient's condition 4
Common Pitfalls to Avoid
- Don't assume bidirectional interaction: While many drug interactions are bidirectional, this one primarily affects aripiprazole levels, not carbamazepine levels
- Don't overlook the need for aripiprazole dose adjustment: Failure to increase the aripiprazole dose may result in treatment failure
- Don't confuse with other antipsychotic-anticonvulsant combinations: Some combinations (like fluvoxamine with aripiprazole) can increase antipsychotic levels, but this is not the case with carbamazepine 3
In summary, when combining Abilify with Tegretol, the primary concern is decreased Abilify effectiveness rather than any change in Tegretol levels.